Target intelligence / Profile preview

Bacterial 30S ribosomal subunit (30S subunit)

Target
30S subunit
Molecular classification
Ribosomal subunit
01

Overview

The Bacterial 30S ribosomal subunit is the smaller component of the prokaryotic 70S ribosome, consisting of 16S ribosomal RNA and approximately 21 ribosomal proteins, with a molecular mass of about 0.85 MDa. It plays essential roles in translation by binding messenger RNA (mRNA), decoding the genetic code through codon-anticodon interactions with transfer RNAs (tRNAs), maintaining the mRNA reading frame, and facilitating translocation with the 50S subunit. The subunit recognizes the Shine-Dalgarno sequence upstream of the start codon via its 16S rRNA, binds initiation factors (IF-1, IF-2, IF-3), and positions f-Met-tRNA at the P-site for initiation. Structural studies reveal dynamic domains (head, platform, body) with key proteins like S1 (stabilizing mRNA), uS11, bS21, and interactions with antibiotics that disrupt these processes. In disease, it serves as a primary antibacterial target, as drugs binding the subunit inhibit bacterial protein synthesis without significantly affecting eukaryotic 80S ribosomes. High-resolution cryo-EM and X-ray structures (down to 2 Å) detail rRNA modifications, protein contacts, and drug binding sites, aiding antibiotic design.

Other names
Prokaryotic small ribosomal subunitsmall subunit of the 70S ribosome
02

Mechanism of action

Interfere with decoding, interfere with translocation

03

Biological functions

Protein synthesismRNA decodingtRNA bindingtranslocationtranslation initiation
04

Disease associations

Infection
05

Interacting drugs

paromomycin

2 more in the full profile.

Beyond the preview

Go deeper on Bacterial 30S ribosomal subunit (30S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial 30S ribosomal subunit (30S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call